ReviewFrontiers in immunology2024

Unlocking the potential of iPSC-derived immune cells: engineering iNK and iT cells for cutting-edge immunotherapy.

Minggang Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.